Product name:Elvitegravir
CAS:697761-98-1
Molecular Formula:C23H23ClFNO5
Formula Weight:447.883g/mol
Description:Elvitegravir is an investigational new drug for the treatment of HIV infection. It acts as an integrase inhibitor.According to the results of the phase II clinical trial, patients taking once-daily elvitegravir boosted by ritonavir had greater reductions in viral load after 24 weeks compared to individuals randomized to receive a ritonavir-boosted protease inhibitor.